North China Pharmaceutical Co Ltd (600812) — Financial Flexibility Index
North China Pharmaceutical Co Ltd (600812) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥314.62 Million (operating CF CN¥170.24 Million minus capex CN¥144.38 Million) represents 0% of total liabilities (CN¥14.86 Billion). Also explore 600812 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
North China Pharmaceutical Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for North China Pharmaceutical Co Ltd across 28 annual periods. Check 600812 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for North China Pharmaceutical Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for North China Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600812 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | CN¥1.72 Billion | CN¥1.18 Billion | CN¥14.51 Billion | ▼ -13.0% |
| 2024 | 0.14x | CN¥2.01 Billion | CN¥1.23 Billion | CN¥14.80 Billion | ▲ +21.3% |
| 2023 | 0.11x | CN¥1.65 Billion | CN¥1.02 Billion | CN¥14.69 Billion | ▲ +8.2% |
| 2022 | 0.10x | CN¥1.55 Billion | CN¥1.00 Billion | CN¥14.99 Billion | ▲ +16.2% |
| 2021 | 0.09x | CN¥1.60 Billion | CN¥1.05 Billion | CN¥17.91 Billion | ▼ -14.4% |
| 2020 | 0.10x | CN¥1.76 Billion | CN¥752.15 Million | CN¥16.88 Billion | ▼ -2.4% |
| 2019 | 0.11x | CN¥1.38 Billion | CN¥732.97 Million | CN¥12.92 Billion | ▲ +3.4% |
| 2018 | 0.10x | CN¥1.28 Billion | CN¥774.33 Million | CN¥12.40 Billion | ▲ +78.4% |
| 2017 | 0.06x | CN¥686.94 Million | CN¥287.25 Million | CN¥11.87 Billion | ▲ +509.8% |
| 2016 | -0.01x | CN¥-157.93 Million | CN¥-446.53 Million | CN¥11.18 Billion | ▼ -130.9% |
| 2015 | 0.05x | CN¥490.31 Million | CN¥122.50 Million | CN¥10.73 Billion | ▲ +35.2% |
| 2014 | 0.03x | CN¥348.86 Million | CN¥90.56 Million | CN¥10.32 Billion | ▼ -17.3% |
| 2013 | 0.04x | CN¥425.92 Million | CN¥-135.03 Million | CN¥10.41 Billion | ▼ -61.7% |
| 2012 | 0.11x | CN¥1.00 Billion | CN¥-63.92 Million | CN¥9.36 Billion | ▼ -22.1% |
| 2011 | 0.14x | CN¥1.36 Billion | CN¥227.60 Million | CN¥9.95 Billion | ▲ +94.9% |
| 2010 | 0.07x | CN¥558.27 Million | CN¥-598.35 Million | CN¥7.94 Billion | ▼ -67.3% |
| 2009 | 0.21x | CN¥1.38 Billion | CN¥1.01 Billion | CN¥6.41 Billion | ▼ -5.8% |
| 2008 | 0.23x | CN¥1.22 Billion | CN¥1.09 Billion | CN¥5.37 Billion | ▲ +55.9% |
| 2007 | 0.15x | CN¥762.64 Million | CN¥664.37 Million | CN¥5.22 Billion | ▲ +26.5% |
| 2006 | 0.12x | CN¥648.84 Million | CN¥597.12 Million | CN¥5.61 Billion | ▲ +56.8% |
| 2005 | 0.07x | CN¥408.84 Million | CN¥224.17 Million | CN¥5.55 Billion | ▼ -34.1% |
| 2004 | 0.11x | CN¥658.89 Million | CN¥310.39 Million | CN¥5.89 Billion | ▼ -50.7% |
| 2003 | 0.23x | CN¥1.02 Billion | CN¥580.32 Million | CN¥4.51 Billion | ▲ +1.1% |
| 2002 | 0.22x | CN¥963.19 Million | CN¥738.50 Million | CN¥4.29 Billion | ▲ +86.1% |
| 2001 | 0.12x | CN¥559.07 Million | CN¥367.28 Million | CN¥4.63 Billion | ▲ +70.6% |
| 2000 | 0.07x | CN¥231.00 Million | CN¥133.49 Million | CN¥3.27 Billion | ▲ +171.7% |
| 1999 | -0.10x | CN¥-285.87 Million | CN¥-373.62 Million | CN¥2.90 Billion | ▲ +32.3% |
| 1998 | -0.15x | CN¥-292.55 Million | CN¥-326.74 Million | CN¥2.01 Billion | — |